drugset / Trial / NCT02528123

VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia

NCT02528123

Completed 114 enrolled London Vision Clinic
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to validate the safety and effectiveness of treating myopia (short-sightedness) higher than -10D using small incision lenticule extraction (SMILE) with the VisuMax femtosecond laser.

Timeline

Start
2016-04
Primary completion
2020-12-07
Completion
2020-12-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Benoxinate Small molecule 0.4 % Topical
Background Dexamethasone Small molecule Topical
Background Ofloxacin Small molecule Topical
Background Proparacaine Other / unclassified 0.5 % Topical
Background Tobramycin Small molecule Topical

Indications